Rationale of Cross-Sectional Descriptive Study on Clinical Effectiveness of Oral Combination Therapy Based on Secnidazole, Azithromycin and Fluconazole in Syndromic Treatment of Abnormal Vaginal Discharge in Kinshasa/DR Congo
Background: Vaginal discharge is one of the most common troubles facedbychildbearing
age women. About 20% -25% of women who visit service of gynecology complain of vaginal
discharge and leucorrhoea. Management of vaginal discharge in low-income
countries generally depends on syndromic approach, which limits the
understanding of specific responsible agents.Thus
targeted management is based on the identification of causal organism and
targeting of therapy against it, while syndromic management is based on
presence of high risk factors.Thus the
oral combination kit (Azimyn FS Kit？) offers convenience of a one-day treatment
compared to other multidose treatments, which will also ensure high patient
adherence to treatment, thus increasing chances of desired results. Due to its
widespread use, it is proposed to evaluate the effectiveness of this oral
association kit therapy in management of vaginal discharge in the population of
our milieu in the Democratic Republic of Congo (DRC) particularly those
received in outpatient consultation in some medical facilities in city of
Kinshasa.
References
[1]
Jogi, S.R. (2015) Vaginal Discharge: Evaluation of Syndromic Management in Chhattisgarh Institute of Medical Sciences, Bilaspur, CG. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 4, 1534-1538.
https://doi.org/10.18203/2320-1770.ijrcog20150691
[2]
Swetha, V., Kannan, G., Asha, D. and Kavitha, A. (2017) Epidemiology and Clinico-Investigative Study of Organisms Causing Vaginal Discharge. Indian Journal of Sexually Transmitted Diseases and AIDS, 38, 69-75.
https://doi.org/10.4103/0253-7184.203433
[3]
Meena, V. and Bansal, C.L. (2016) Study to Assess Targeted Management and Syndromic Management in Women with Abnormal Vaginal Discharge. The Journal of Obstetrics and Gynecology of India, 66, 534-540.
https://doi.org/10.1007/s13224-016-0879-x
[4]
Murewanhema, G., Moyo, E., Mhango, M., Chitango, I., Moyo, P., Musuka, G., et al. (2022) Abnormal Vaginal Discharge in Women of Reproductive Age in Sub-Saharan Africa: The Need for a Paradigm Shift from a Syndromic Approach to Specific Pathogen Identification and Directed Treatment. IJID Regions, 29, 165-168.
https://doi.org/10.1016/j.ijregi.2022.10.006
[5]
Onyekonwu, C.L., Olumide, Y.M., Oresanya, F.A. and Onyekonwu, G.C. (2011) Vaginal Discharge: Etiological Agents and Assessment of Syndromic Management in Lagos. Nigerian Journal of Medicine, 20, 155-162.
[6]
Rubio-Sanchez, R., Rios-Reina, R. and Ubeda, C. (2023) Identification of Volatile Biomarkers of Trichomonas vaginalis Infection in Vaginal Discharge and Urine. Applied Microbiology and Biotechnology, 107, 3057-3069.
https://doi.org/10.1007/s00253-023-12484-6
[7]
Bruins, M.J., Dos Santos, C.O., Damoiseaux, R.A.M.J. and Ruijs, G.J.HM. (2021) Bacterial Agents in Vulvovaginitis and Discharge Vaginas: A 10-Year Retrospective Study in the Netherlands. European Journal of Clinical Microbiology & Infectious Diseases, 40, 2123-2128. https://doi.org/10.1007/s10096-021-04265-8
[8]
Reiter, S. and Kellogg, S. (2019) Bacterial Vaginosis: An Introduction for Clinicians. Postgraduate Medicine, 131, 8-18. https://doi.org/10.1080/00325481.2019.1546534
[9]
Majigo, M.V., Kashindye, P., Mtulo, Z. and Joachim, A. (2021) Bacterial Vaginosis, the Leading Cause of Genital Discharge among Women Presenting with Vaginal Infection in Dar es Salaam, Tanzania. African Health Sciences, 21, 531-537.
https://doi.org/10.4314/ahs.v21i2.7
[10]
Nicole, H.D. and Petra, F.W. (2019) Efficacy of Azithromycin and Doxycycline Treatment in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study. FemCure, 69, 1946-1954.
https://doi.org/10.1093/cid/ciz050
[11]
Romero Herrero, D. and Andreu Domingo, A. (2016) Vaginosis Bacteriana [Bacterial Vaginosis]. Enfermedades Infecciosas y Microbiología Clínica, 34, 14-18.
https://doi.org/10.1016/S0213-005X(16)30214-2
[12]
Kadima, M.C., Kabongo, A., Kadima, L.C., Uwonda, A.S., Mbuyamba, N.L. and Mwembo, T.A. (2022) Frequency and Causes of Female Infertility in Mbujimayi, DRC. Mali Medical, 37, 54-60.
[13]
Sharma, J., Chanana, C., Mittal, S. and Raina, U. (2005) A Prospective Study of Comparison of Efficacy of Two Combination Treatment Regimens in Syndromic Treatment of Pelvic Inflammatory Disease. The Internet Journal of Gynecology and Obstetrics, 5, 1-5. https://doi.org/10.5580/333
[14]
Christina, A.M. and Jane, R.S. (2021) Efficacy and Safety of a Single Oral Dose of Secnidazole for Trichomoniasis in Women: Results of a Randomized Phase 3 Study in Double-Blind, Placebo-Controlled, Treatment-Based Deferred. Clinical Infectious Diseases, 73, e1282-e1289. https://doi.org/10.1093/cid/ciab242
[15]
Melo, A., Ossa, X., Fetis, G., Lazo, L., Bustos, L. and Fonseca-Salamanca, F. (2021) Concordance between Clinical and Laboratory Diagnosis of Abnormal Vaginal Discharge in Chilean Women. Revista Brasileira de Ginecologia e Obstetrícia, 43, 600-607. https://doi.org/10.1055/s-0041-1735299
[16]
Serwin, A.B., Bulhak-Koziol, V., Sokolowska, M., Golparian, D. and Unemo, M. (2017) Trichomonas Vaginalis Is Very Rare among Women with Vaginal Discharge in Podlaskie Province, Poland. Acta Pathologica et Microbiologica Scandinavica, 125, 840-843. https://doi.org/10.1111/apm.12713
